We work alongside GP practices to support their veteran patients at home. Referrals are made using the DVA D904 form. We provide assessments, ongoing nursing care and regular feedback to the referring GP.
Veterans with skin cancer: information for GPs and practice nurses
In recent years, under the newer Non Liability Health Care (NLHC) system, many veterans have received treatment for malignant neoplasms of the skin under DVA NLHC arrangements.
From 1 July 2026, the Presumptive Liability Determination 2026, made under the Military Rehabilitation and Compensation Act 2004, provides that basal cell carcinoma (BCC), squamous cell carcinoma (SCC), malignant melanoma and solar (actinic) keratosis may be accepted on a presumptive basis. This applies where the veteran has rendered at least 56 weeks of full time peacetime service, or 29 weeks of warlike or non warlike service, and the claim is lodged on or after 1 July 2026. Only full time service counts toward these periods. Where a veteran’s service was mainly part time Reserve service, the claim may instead be assessed under the relevant Statement of Principles.
NLHC and liability are separate. NLHC funds treatment without accepting that service caused the condition. An accepted claim may provide ongoing treatment and related support, and in some cases compensation. Where a claim is lodged, NLHC treatment may be considered as part of that claim with the veteran’s written consent, and remains in place if the claim is not accepted.
Practitioners may wish to raise the option of a claim with eligible patients and encourage them to seek further support. A claim requires DVA’s Diagnosis Form (D9287). Histopathology is essential for BCC and SCC.
Veterans may benefit from the support of an Advocate when considering these steps.
NOTE: DVA policy and legislation change from time to time. This is general information only, and is not clinical, legal or DVA advice.
Sources
